companydata.dkOLANDER CLINICAL CONSULTING 1 ApS: Financial statements 2023
CVR: 35532900
OLANDER CLINICAL CONSULTING 1 ApS (CVR 35532900) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 0 and a net result of DKK 23,757 compared with DKK 29,664 the year before. Equity amounted to DKK 107,703. The solvency ratio was 91.3%.
- Revenue
- 0 kr.
- Gross Profit
- -7,581 kr.
- Profit/Loss
- 23,757 kr.
- Equity
- 107,703 kr.
- Total Assets
- 118,011 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 0 | -8 t. | 24 t. | 108 t. | - |
| 2022 | - | -7 t. | 30 t. | 114 t. | - |
| 2021 | - | -7 t. | 29 t. | 109 t. | - |
| 2020 | - | -6 t. | 23 t. | 104 t. | - |
| 2019 | - | -6 t. | 22 t. | 108 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
OLANDER CLINICAL CONSULTING 1 ApS has published its annual report for 2022. Gross profit came to DKK -7,257, and the net result was DKK 29,664.
About OLANDER CLINICAL CONSULTING 1 ApS
OLANDER CLINICAL CONSULTING 1 ApS is a Danish company of the type Anpartsselskab based in Snekkersten, founded in 2013. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Birgitte Aae Olander. The company is owned by Birgitte Aae Olander. The company has 0 employees. In 2025, the company reported a gross profit of DKK 38,365 and a net result of DKK 28,455 compared with DKK 30,979 the year before. Equity amounted to DKK 167,137.